Spark Investment Management’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
Other funds holding BPMC
CC
HA
Spark Investment Management's BPMC Position: Q2 2020 in Review
Spark Investment Management sold out of Blueprint Medicines (BPMC) in Q2 2020, closing a stake of 5,041 shares — an estimated $294K sold.
Spark Investment Management first reported a position in BPMC in Q4 2015 and held it in 17 quarters. The position peaked at $11.5M in Q2 2019. 235 funds tracked by Wall St. Rank hold BPMC as of Q2 2020.
- Spark Investment Management reported no remaining Blueprint Medicines position as of Q2 2020 after selling out during the quarter.
- Spark Investment Management sold 5,041 Blueprint Medicines shares in Q2 2020, an estimated $294K.
- Spark Investment Management first reported a position in Blueprint Medicines in Q4 2015 and held it in 17 quarters.
- Spark Investment Management's Blueprint Medicines position peaked at $11.5M in Q2 2019.
- 235 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2020.
Based on Spark Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.